Introduction

A research team in Sydney has announced that a human liver remained viable outside the human body for seven weeks, a duration that far exceeds anything previously documented. The organ was sustained using an automated system known as the Extended Organ Perfusion System, which circulates blood, delivers nutrients, and removes waste while maintaining the liver at normal body temperature. Although the full findings have not yet been published in a peer-reviewed journal, the achievement suggests a potential shift in how transplant organs are stored, evaluated, and even modified before reaching a recipient.

What Happened

Led by transplant surgeon Carlo Pulitano of Royal Prince Alfred Hospital and the University of Sydney, the Australian group connected a donated liver to a network of automated pumps and sensors. Pulitano likened the setup to an artificial body because it mimics physiological conditions at roughly 37 degrees Celsius. The team reported that it is the only group worldwide to maintain a human liver under fully normothermic conditions for this length of time.

The previous benchmark, set by a Swiss team, was approximately two weeks. Most donor organs currently last only a few hours when packed in ice, which creates intense logistical pressure to complete transplants quickly. Perfusion technology has already begun extending that window, but the Sydney result represents a dramatic leap. According to Pulitano, automation was the critical factor. In a comparison described earlier this year, livers managed by an automated system survived an average of about four weeks—roughly three times longer than those requiring manual adjustments.

Why This Matters

Longer preservation times could ease the severe shortage of transplant organs by allowing more time for transport, matching, and preparation. There is also evidence that organs placed on perfusion may begin to repair themselves, potentially making lower-quality donor livers suitable for transplant. Pulitano's startup, Aeternum Life Technologies, plans to test this idea in Sydney by transplanting marginal livers that have been supported for four days.

Beyond transplantation, extended perfusion creates a living platform for human organ research outside the body. Scientists could test gene therapies, study drug responses, or explore organ regeneration without relying on animal models. Pulitano has already experimented with adding gene therapies to perfused livers and has explored splitting a donor liver and growing both portions on the machine, taking advantage of the liver's natural ability to regenerate over roughly two months.

Key Takeaways

  • Australian researchers kept a human liver alive outside the body for seven weeks using automated machine perfusion.
  • The Extended Organ Perfusion System maintained the organ at normal body temperature while supplying nutrients and removing waste.
  • The result surpasses the previous record of about two weeks, set in Switzerland.
  • Automation appears to be a major factor, with automated perfusion tripling average survival times in the team's experience.
  • The work is still awaiting formal publication, and some experts question how an organ preserved for nearly two months would be used clinically.
  • Potential applications include improved transplant logistics, organ repair, gene therapy testing, and new approaches to growing transplantable tissue.

Conclusion

The seven-week liver experiment pushes the boundaries of what is possible with organ life support, but it also raises practical questions. Whether clinicians will ultimately need or want organs kept viable for nearly two months remains uncertain. Still, the research reflects a broader shift in transplant medicine, moving from simple cold storage toward active organ maintenance and manipulation. As new scientific societies form around perfusion and organ medicine, the technology may soon reshape not only how transplants are performed but also how scientists study and engineer human organs.